Skip to main content
    M

    Mereo BioPharma Group PLC ADR (MREO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.30
    -0.00 (-0.81%)

    Market Cap: $49.11M

    Last updated: Nov 17, 2026 at 11:01 AM ET

    Mereo BioPharma Group PLC ADR (MREO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Mereo BioPharma Group PLC ADR are Mural Oncology (MURA), Spero Therapeutics (SPRO) and Biomea Fusion (BMEA). By market cap, Mereo BioPharma Group PLC ADR ranks 5th of the 13 companies on this page; Neumora Therapeutics (NMRA) is the largest at $80.59M.

    Peer Comparison

    MREO's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Mereo BioPharma Group PLC ADR (MREO)$49.11MN/A61.3x0.0%-116.6%0.0%0.00%
    Mural Oncology plc (MURA)$35.38MN/AN/A0.0%-173.6%0.0%0.00%
    Spero Therapeutics Inc (SPRO)$58.26M11.1x1.3x15.7%N/A-95.6%0.00%
    Biomea Fusion Inc (BMEA)$42.31MN/AN/A0.0%N/A0.0%0.00%
    MAIA Biotechnology Inc. (MAIA)$61.75MN/AN/A0.0%N/A0.0%0.00%
    Veru Inc (VERU)$35.64MN/AN/A0.0%N/A18.3%0.00%
    Tiziana Life Sciences Ltd (TLSA)$72.53MN/AN/A0.0%N/A0.0%0.00%
    Neumora Therapeutics, Inc. (NMRA)$80.59MN/AN/A0.0%-260.5%0.0%0.00%
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)$36.15MN/AN/A0.0%N/A0.0%0.00%
    Immutep Ltd ADR (IMMP)$25.64MN/A2.2x0.0%N/A633.0%0.00%
    Oncolytics Biotech Inc (ONCY)$48.51MN/AN/A0.0%N/A0.0%0.00%
    INmune Bio Inc (INMB)$32.51MN/AN/A0.0%N/A257.1%0.00%
    Grace Therapeutics, Inc. (GRCE)$38.08MN/AN/A0.0%N/A0.0%0.00%
    Peer median$40.19M11.1x1.8x0.0%-217.0%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Mereo BioPharma Group PLC ADR, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Mural Oncology plc (MURA)
    Mural Oncology plc is a pioneering biotechnology company dedicated to developing targeted therapies for solid tumors...
    Spero Therapeutics Inc (SPRO)
    Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing...
    SPRO competitors
    Biomea Fusion Inc (BMEA)
    Biomea Fusion, Inc., a biopharmaceutical company, is focused on the discovery, development and commercialization of irreversible small molecules to treat...
    BMEA competitors
    MAIA Biotechnology Inc. (MAIA)
    MAIA Biotechnology Inc. is an innovative biotechnology company focused on developing cutting-edge cancer therapies that significantly improve patient outcomes...
    MAIA competitors
    Veru Inc (VERU)
    Veru Inc., an oncology biopharmaceutical company, focuses on the development of drugs for the treatment of cancers.
    VERU competitors
    Tiziana Life Sciences Ltd (TLSA)
    Tiziana Life Sciences Plc, a clinical-stage biotechnology company, focuses on the discovery and development of molecules and related diagnostics to treat...
    Neumora Therapeutics, Inc. (NMRA)
    Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases...
    NMRA competitors
    Telomir Pharmaceuticals, Inc. Common Stock (TELO)
    Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human...
    TELO competitors
    Immutep Ltd ADR (IMMP)
    Immutep Limited, a biotechnology company, is dedicated to the research and development of pharmaceutical candidates.
    Oncolytics Biotech Inc (ONCY)
    Oncolytics Biotech Inc., a developing-stage biopharmaceutical company, focuses on the discovery and development of pharmaceuticals for the treatment of cancer.
    ONCY competitors
    INmune Bio Inc (INMB)
    INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease...
    INMB competitors
    Grace Therapeutics, Inc. (GRCE)
    Grace Therapeutics, Inc. engages in the development and commercialization of pharmaceutical products for rare and orphan diseases in Canada.
    GRCE competitors

    Frequently Asked Questions About MREO

    Who are Mereo BioPharma Group PLC ADR's main competitors?

    The companies most similar to Mereo BioPharma Group PLC ADR include Mural Oncology (MURA), Spero Therapeutics (SPRO), Biomea Fusion (BMEA), MAIA Biotechnology (MAIA) and Veru (VERU), listed from the closest match.

    Who is Mereo BioPharma Group PLC ADR's biggest competitor?

    Neumora Therapeutics (NMRA) is the largest of the similar companies at $80.59M; Mural Oncology (MURA) is the closest match by business profile, size, sector and industry.

    How does MREO stock compare with its competitors?

    MREO's P/S is 61.3x against a peer median of 1.8x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Mereo BioPharma Group PLC ADR's competitors pays a higher dividend?

    Mereo BioPharma Group PLC ADR pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Mereo BioPharma Group PLC ADR bigger than its competitors?

    No. Mereo BioPharma Group PLC ADR is 5th by market cap among the 13 companies on this page; the largest is Neumora Therapeutics (NMRA) at $80.59M.